Authors: PERLMAN HR KRASINSKI K SATA M DORAI T BUTTYAN R WALSH K

Citation: Hr. Perlman et al., HAMMERHEAD RIBOZYME-MEDIATED DISRUPTION OF BCL-2 INDUCES APOPTOSIS AND BLOCKS CELL-CYCLE PROGRESSION THROUGH THE PROTEOLYTIC DEGRADATION OFCYCLIN-A IN VASCULAR SMOOTH-MUSCLE CELLS, Circulation, 98(17), 1998, pp. 3138-3138

Authors: DORAI T OLSSON CA KATZ AE BUTTYAN R

Citation: T. Dorai et al., DEVELOPMENT OF A HAMMERHEAD RIBOZYME AGAINST BCL-2 .1. PRELIMINARY EVALUATION OF A POTENTIAL GENE THERAPEUTIC AGENT FOR HORMONE-REFRACTORY HUMAN PROSTATE-CANCER, The Prostate, 32(4), 1997, pp. 246-258

Authors: DORAI T GOLUBOFF ET OLSSON CA BUTTYAN R

Citation: T. Dorai et al., DEVELOPMENT OF A HAMMERHEAD RIBOZYME AGAINST BCL-2 .2. RIBOZYME TREATMENT SENSITIZES HORMONE-RESISTANT PROSTATE-CANCER CELLS TO APOPTOTIC AGENTS, Anticancer research, 17(5A), 1997, pp. 3307-3312

Authors: DORAI T KOBAYASHI H HOLLAND JF OHNUMA T

Citation: T. Dorai et al., MODULATION OF PLATELET-DERIVED GROWTH-FACTOR-BETA MESSENGER-RNA EXPRESSION AND CELL-GROWTH IN A HUMAN MESOTHELIOMA CELL-LINE BY A HAMMERHEAD RIBOZYME, Molecular pharmacology, 46(3), 1994, pp. 437-444

Authors: KOBAYASHI H DORAI T HOLLAND JF OHNUMA T

Citation: H. Kobayashi et al., REVERSAL OF DRUG-SENSITIVITY IN MULTIDRUG-RESISTANT TUMOR-CELLS BY ANMDR1 (PGY1) RIBOZYME, Cancer research, 54(5), 1994, pp. 1271-1275